Vardhman Exports Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Vardhman Exports Pharmaceutical Export Portfolio Dataset — 4 Products, $2.2M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Vardhman Exports — Pharmaceutical Exporter Profile (2026) | 4 Products, $2.2M Trade | TransData Nexus

Vardhman Exports

Indian Pharmaceutical Exporter · Nutritional Supplements Specialist · $2.2M Total Trade · DGFT Verified

Vardhman Exports is an Indian pharmaceutical exporter with a total trade value of $2.2M across 4 products in 3 therapeutic categories. Based on 235 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Vitamin ($1.6M), Salicylic ($273.6K), Acetylsalicylic ($219.6K).

Vardhman Exports — Export Portfolio & Destination Treemap

Vardhman Exports pharmaceutical export portfolio — 4 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Vardhman Exports? — Company Overview & Market Position

Vardhman Exports, established in 1978, is a prominent Indian pharmaceutical exporter specializing in the production and marketing of finished pharmaceutical formulations. The company is headquartered at 586-A, Kuntal Building, Mody Estate, LBS Marg, Ghatkopar (West), Mumbai-400086, India. Its manufacturing facility is located at A-188, TTC, MIDC Industrial Area, Khairne, Navi Mumbai – 400710, India. (vardhman.biz)

The ownership structure of Vardhman Exports is not publicly disclosed. The company operates under the Corporate Identification Number (CIN) U51398MH1997PTC108929, as per records from the Registrar of Companies, Mumbai. While specific revenue figures are not publicly available, the company has been recognized for its quality and ethical practices, receiving multiple national awards. Vardhman Exports employs between 101 and 250 people, reflecting its substantial operational scale.

What Does Vardhman Exports Export? — Product Portfolio Analysis

Top Products by Export Value

1Vitamin$1.6M 2Salicylic

Product Portfolio — Top 4 by Export Value

Vardhman Exports exports 4 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Vitamin	Nutritional Supplements	$1.6M	193	1.1%	15
2	Salicylic	Combination Drugs	$273.6K	16	1.6%	11
3	Acetylsalicylic	Combination Drugs	$219.6K	9	5.0%	7
4	Pyrantel	Antimalarial & Antiparasitic	$80.9K	17	2.5%	7

Vardhman Exports exports 4 pharmaceutical products across 3 therapeutic categories with a total export value of $2.2M. The top category is Nutritional Supplements (73.4% of portfolio), followed by Combination Drugs (22.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Vardhman Exports — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Vardhman Exports operates a WHO-GMP certified manufacturing facility located at A-188, TTC, MIDC Industrial Area, Khairne, Navi Mumbai – 400710, India. (vardhman.biz) The facility specializes in the production of various pharmaceutical dosage forms, including tablets, capsules, syrups, ointments, creams, and injections. This comprehensive manufacturing capability enables the company to cater to a diverse range of therapeutic areas and meet the specific needs of different markets.

3Key Leadership

The leadership team at Vardhman Exports comprises seasoned professionals with extensive experience in the pharmaceutical industry. Mr. Lalit Shah and Mr. Ramesh Shah are integral members of the core management team, contributing significantly to the company's strategic direction and growth. (vardhman.biz) The next generation of leadership includes Mr. Prashant Shah, Mr. Kashyap Shah, and Mr. Ankit Shah, who are actively involved in the company's operations, ensuring continuity and the infusion of innovative ideas. Their combined expertise and commitment to quality have been pivotal in establishing Vardhman Exports as a reputable name in the pharmaceutical export sector.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Vardhman Exports Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Vardhman Exports has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facility holds WHO-GMP certification, which is a prerequisite for exporting pharmaceutical products to many of these regions. While specific regulatory filings and approvals in these markets are not publicly disclosed, the WHO-GMP certification indicates compliance with international manufacturing standards, facilitating market access. The company's export activities are likely supported by adherence to the regulatory requirements of these regions, enabling it to supply a range of pharmaceutical formulations to meet global demand.

2Emerging Markets

Vardhman Exports has strategically penetrated emerging markets in Africa, Latin America, and Southeast Asia. The company's focus on countries such as Nigeria, Zambia, Ghana, Bolivia, and Vietnam underscores its commitment to expanding its global footprint. The WHO-GMP certification of its manufacturing facility enhances the company's ability to meet the quality standards required for these markets, facilitating smoother entry and acceptance. By aligning its product offerings with the specific health needs of these regions, Vardhman Exports aims to contribute to improving healthcare outcomes and establishing long-term partnerships.

Geographic Strategy

Vardhman Exports — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Vardhman Exports' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's WHO-GMP certification indicates compliance with international manufacturing standards, which is a prerequisite for exporting pharmaceutical products to the United States. While the absence of publicly disclosed FDA approvals may limit direct market access, the company's adherence to recognized quality standards suggests a commitment to meeting regulatory requirements for potential entry into the U.S. market.

2WHO & EU GMP

Vardhman Exports' manufacturing facility holds WHO-GMP certification, ensuring compliance with international manufacturing standards. This certification is recognized by the European Union and other global regulatory bodies, facilitating the company's ability to export pharmaceutical products to these regions. The adherence to WHO-GMP standards underscores the company's commitment to quality assurance and regulatory compliance, enhancing its credibility in international markets.

3CDSCO & Indian Regulatory

Vardhman Exports — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Vardhman Exports operates in a competitive landscape with several key players in the pharmaceutical export sector. While specific market share data is not publicly available, the company's focus on a diverse product portfolio, including tablets, capsules, syrups, ointments, creams, and injections, positions it to compete effectively across various therapeutic categories. The WHO-GMP certification of its manufacturing facility enhances its credibility and competitiveness in international markets. By aligning its product offerings with the specific health needs of diverse populations, Vardhman Exports aims to establish a strong market presence and differentiate itself from competitors.

2Key Differentiators

Vardhman Exports' key differentiators include its extensive experience in the pharmaceutical industry, a diverse product portfolio, and a commitment to quality assurance. The company's WHO-GMP certified manufacturing facility underscores its adherence to international manufacturing standards. Additionally, the leadership team's strategic vision and the integration of new and old generations in the management structure contribute to the company's ability to adapt to market dynamics and implement innovative solutions. (vardhman.biz)

3Strategic Position

Buyer Due Diligence Brief — Evaluating Vardhman Exports as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Vardhman Exports has a track record of exporting pharmaceutical products to over 14 countries across four continents, including regions in Africa, Asia, Central/South America, Europe, the Far East, Near/Middle East, Australia/New Zealand, and North America. The company's manufacturing facility holds WHO-GMP certification, indicating compliance with international manufacturing standards. While specific export volume and consistency data are not publicly available, the company's broad market presence and adherence to quality standards suggest reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Confirms adherence to international manufacturing standards.

FDA Facility Registration: Indicates compliance with U.S. Food and Drug Administration regulations.

Frequently Asked Questions — Vardhman Exports

How many pharmaceutical products does Vardhman Exports export from India?

Vardhman Exports exports 4 pharmaceutical products across 3 therapeutic categories. The top exports are Vitamin ($1.6M), Salicylic ($273.6K), Acetylsalicylic ($219.6K), Pyrantel ($80.9K). Total export value is $2.2M.

What is Vardhman Exports's total pharmaceutical export value?

Vardhman Exports's total pharmaceutical export value is $2.2M, based on 235 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Vardhman Exports cover?

Vardhman Exports exports across 3 therapeutic categories. The largest are Nutritional Supplements (73.4%, 1 products), Combination Drugs (22.9%, 2 products), Antimalarial & Antiparasitic (3.8%, 1 products).

Get Full Vardhman Exports Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.